Chennai, India – Eva Feldman, M.D., Ph.D., Director of the Program for Neurology Research & Discovery, was one of two keynote speakers at the 2019 Indo U.S. U.K. Conclave, hosted by the M.V. Hospital for Diabetes & Professor M Viswanathan Diabetes Research Center. The theme of the September event was preventing nerve and kidney disease in patients with diabetes.
Dr. Feldman gave a presentation entitled “Diagnosis of Diabetic Neuropathy in the Clinical Setting: What Should a Clinician Know?” A member of the board of directors for the M.V. Hospital for Diabetes, Dr. Feldman was making her fifth trip to India. Her collaboration with Vijay Viswanathan, M.D., Ph.D., head & chief diabetologist at the M.V. Hospital, dates back to her first visit to India in 2014. Drs. Feldman and Viswanathan are together conducting studies in M.V. Hospital to determine the prevalence of nerve, kidney and eye disease in patients with newly diagnosed prediabetes and diabetes, and comparing these findings to parallel studies being conducted in the USA. The goal is to understand how different diets, climate and lifestyles, along with genetic risk factors, influence the development of damage to vital organs in diabetes. In June 2019, Dr. Feldman was the lead author of “Diabetic Neuropathy” in Nature Reviews Disease Primers (one-page summary) where Dr. Viswanathan was a contributing author. She highlighted the work she and Dr. Viswanathan are conducting during her presentation at the Indo U.S. U.K. Conclave.
M.V. Hospital for Diabetes situated at Royapuram, Chennai, was established by late Professor M. Viswanathan in 1954 as a general hospital. In 1971 it became a hospital exclusively for diabetes care. Under Dr. M. Viswanathan’s leadership, the hospital has grown to achieve the status of a teaching institution of international excellence. It has, at present, 100 beds for the treatment of diabetes and its complications. Over the years it has grown to be one of the largest referral centers for diabetes, with more than three million patients registered to-date. It is recognized as an internationally-known tertiary care center for referral of diabetic patients. Drs. Feldman and Viswanathan are currently applying to the National Institutes of Health for funding to support their groundbreaking studies.